Boehringer Ingelheim signs Option to Acquire Trutino Biosciences
INGELHEIM, Germany & SAN DIEGO–(BUSINESS WIRE)–Boehringer Ingelheim today announced the signing of an option to acquire Trutino Biosciences Inc. (the “Transaction”), a San Diego-based biotech company. Trutino Biosciences is a pre-clinical stage biotech company dedicated to the discovery and development of next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases. Boehringer Ingelheim is dedicated to … [Read more…]
